Evidence map›Paper›PMID 38933925›Full record

ArticleFrontiers in genetics2024

Polymorphism Pro64His within galectin-3 has functional consequences at proteome level in thyroid cells.

Roberto Silvestri, Lorenzo Zallocco, Alda Corrado, Maurizio Ronci, Romina Aceto, Benedetta Ricci, Monica Cipollini, Irene Dell'Anno, Chiara De Simone, Giuseppina De Marco and 7 more

Abstract read
In one paragraph

Article in Frontiers in genetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Roberto Silvestri *Department of Biology, Genetic Unit, University of Pisa, Pisa, Italy.
Lorenzo Zallocco *Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
Alda Corrado *Department of Biology, Genetic Unit, University of Pisa, Pisa, Italy.
Maurizio RonciDepartment of Medical, Oral and Biotechnological Sciences, University "G.D'Annunzio" of Chieti-Pescara, Chieti, Italy.
Romina AcetoDepartment of Biology, Genetic Unit, University of Pisa, Pisa, Italy.
Benedetta RicciDepartment of Biology, Genetic Unit, University of Pisa, Pisa, Italy.
Monica CipolliniDepartment of Biology, Genetic Unit, University of Pisa, Pisa, Italy.
Irene Dell'AnnoDepartment of Biology, Genetic Unit, University of Pisa, Pisa, Italy.
Chiara De SimoneDepartment of Medical, Oral and Biotechnological Sciences, University "G.D'Annunzio" of Chieti-Pescara, Chieti, Italy.
Giuseppina De MarcoDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Eleonora FerrariniDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Daniela BeghelliSchool of Biosciences and Veterinary Medicine, Via Gentile III da Varano, University of Camerino, Camerino, Italy.
Maria Rosa MazzoniDepartment of Pharmacy, University of Pisa, Pisa, Italy.
Antonio LucacchiniDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Federica GemignaniDepartment of Biology, Genetic Unit, University of Pisa, Pisa, Italy.
Laura Giusti *School of Pharmacy, University of Camerino, Camerino, Italy.
Stefano Landi *Department of Biology, Genetic Unit, University of Pisa, Pisa, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The single nucleotide polymorphism (SNP) rs4644 at codon 64 of galectin-3 (gal-3, gene name: Materials and methods: To deepen our understanding of the biological effects of this SNP, we analyzed the proteome of two isogenic cell lines (NC-P64 vs. NA-H64) derived from the immortalized non-malignant thyrocyte cell line Nthy-Ori, generated through the CRISPR-Cas9 technique to differ by rs4644 genotype. We compared the proteome of these cells to detect differentially expressed proteins and studied their proteome in relation to their transcriptome. Results: Firstly, we found, consistently with previous studies, that gal-3-H64 could be detected as a monomer, homodimer, and heterodimer composed of one cleaved and one uncleaved monomer, whereas gal-3-P64 could be found only as a monomer or uncleaved homodimer. Moreover, results indicate that rs4644 influences the expression of several proteins, predominantly upregulated in NA-H64 cells. Overall, the differential protein expression could be attributed to the altered mRNA expression, suggesting that rs4644 shapes the function of gal-3 as a transcriptional co-regulator. However, this SNP also appeared to affect post-transcriptional regulatory mechanisms for proteins whose expression was oppositely regulated compared to mRNA expression. It is conceivable that the rs4644-dependent activities of gal-3 could be ascribed to the different modalities of self-dimerization. Conclusion: Our study provided further evidence that rs4644 could affect the gal-3 functions through several routes, which could be at the base of differential susceptibility to diseases, as reported in case-control association studies.

Indexed as

CRISPR/Cas9differentiated thyroid carcinoma (DTC)functional polymorphism rs4644galectin-3 (gal3)papillary thyroid carcinoma (PTC)proteome

Identifiers

PMID38933925
PMCPMC11199678

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.